European Economic
and Social Committee
Prices of medicinal products for human use
Download — EESC opinion: Prices of medicinal products for human use
See EESC opinion in all languages under Related documents at the end of this page.
Other relevant EESC opinions:
- Opinion on Prices of medicinal products for human use (CESE 1573/2012, INT/642)
- Opinions on pharmaceuticals
For more information please contact the INT Section Secretariat.
Recommended for you
Medicinal products for human and investigational use / Derogations
Opinion
The EESC:welcomes this package of measures;recognises that need to pay particular attention to the situation of smaller EU Member States, Cyprus, Ireland and Malta in particula;stresses in particular…
Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland
Opinion
In accordance with the EU-UK Withdrawal Agreement, Regulation (EC) No 726/2004 and Directive 2001/83/EC as well as the Commission acts based on them, apply to and in the UK in respect of Northern…
Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland
News
Background The proposed regulation sets out a comprehensive set of joint solutions agreed between the EU and the UK, providing derogations from certain obligations concerning certain medicinal…
Packaging and labelling of veterinary medicinal products – transitional rules
Opinion
Since the Committee endorses the content of the proposal and feels that it requires no comment on its part, it decided, at its 568th plenary session of 23 and 24 March 2022 (meeting of 23 March), to…
Energy prices
Opinion
Key points The analysis by the Commission shows that the most intensive impact on the energy price rally comes from the sharp global increase in the demand for gas and was further pushed by the…